algorithms.eod_public.1.0.tables.ss2018_pleura_60930.json Maven / Gradle / Ivy

{
  "id" : "ss2018_pleura_60930",
  "algorithm" : "eod_public",
  "version" : "1.0",
  "name" : "SS2018: Pleura Mesothelioma",
  "title" : "Summary Stage 2018: Pleura Mesothelioma",
  "subtitle" : "Summary Stage 2018",
  "notes" : "**Pleura Mesothelioma**\n\nC340-C343, C348-C349, C384\nC340 Main bronchus\nC341 Upper lobe, lung\nC342 Middle lobe, lung\nC343 Lower lobe, lung\nC348 Overlapping lesion of lung\nC349 Lung, NOSC384\nC384 Pleura, NOS\n\n**Note 1:** The following sources were used in the development of this schema\n* SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf)\n* SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/)\n* Collaborative Stage Data Collection System, version 02.05:  https://cancerstaging.org/cstage/Pages/default.aspx \n* Chapter 37 *Malignant Pleural Mesothelioma*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois.\n\n**Note 2:** Code 0 is not applicable for this schema.\n\n**Note 3:** Most pleural effusions are due to tumor. When the cytopathological examinations of pleural fluid are negative for tumor, the effusion should be excluded as a staging element and the tumor should not be classified as metastasis.\n* The physician statement of pleural effusion can be used to code this data item\n* If the physician feels the pleural effusion is due to tumor, despite negative cytology, the physician’s assessment can be used to code EOD Mets\n* If pleural fluid cytology is described as suspicious/suspicious for mesothelioma, code 7",
  "footnotes" : "(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998\n\n(2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.\n\n(3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL)\n\n(4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 3-30\n\n(5) Rusch, V.W., et al. **Malignant Plural Mesothelioma**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 457-468",
  "last_modified" : "2018-03-12T16:39:57.622Z",
  "definition" : [ {
    "key" : "ss2018",
    "name" : "SS2018",
    "type" : "INPUT"
  }, {
    "key" : "description",
    "name" : "Description",
    "type" : "DESCRIPTION"
  } ],
  "rows" : [ [ "1", "Localized only (localized, NOS)\n- Confined to pleura, NOS\n- Invasive tumor (mesothelioma) confined to pleura, NOS \n- Ipsilateral parietal pleura WITH or WITHOUT involvement of\n  + Diaphragmatic pleural\n  + Mediastinal pleura \n  + Parietal pleura\n  + Visceral pleura" ], [ "2", "Regional by direct extension only\n- Adjacent (connective) tissue, NOS\n- Chest wall \n- Confluent visceral pleural tumor (including any involvement of interlobar fissure)\n- Diaphragmatic muscle\n- Endothoracic fascia\n- Ipsilateral pleural surfaces all involved \n  + Diaphragmatic, parietal, mediastinal, and visceral\n- Lung parenchyma, or lung involvement, NOS\n- Mediastinal fat (mediastinal tissues)\n- Mediastinal organs (direct extension)\n- Nodule(s) beneath visceral pleural surface (ipsilateral pleura)\n- Pericardium (extension through the internal surface) (non-transmural, NOS) WITHOUT pericardial effusion\n- Pulmonary parenchyma (visceral pleural extension)\n- Rib" ], [ "3", "Regional lymph node(s) involved only\n- Aortic (above diaphragm), NOS\n  + Ascending aorta (phrenic)\n  + Peri/para-aortic\n  + Subaortic (aortico-pulmonary window)\n- Carinal (tracheobronchial) (tracheal bifurcation)\n- Hilar (ipsilateral)\n  + Bronchopulmonary\n  + Proximal lobar\n  + Pulmonary root\n- Intercostal\n- Internal mammary (parasternal)\n- Intrapulmonary\n  + Interlobar\n  + Lobar\n  + Segmental\n  + Subsegmental\n- Mediastinal, NOS (ipsilateral)\n  + Anterior\n  + Posterior (tracheoesophageal)\n- Pericardial\n- Peri/parabronchial\n- Peri/paraesophageal (below carina)\n- Peri/paratracheal (lower [azygos], upper, NOS)\n- Pretracheal and retrotracheal (precarinal), NOS\n- Prevascular\n- Pulmonary ligament\n- Subcardial\n- Subcarinal\n- Regional lymph node(s), NOS\n  + Lymph node(s), NOS" ], [ "4", "Regional by BOTH direct extension AND regional lymph node(s) involved\n- Codes (2) + (3)" ], [ "7", "Distant site(s)/lymph node(s) involved\n- Distant site(s) (including further contiguous extension)\n  + Brachial plexus\n  + Cervical (neck) tissues\n  + Contralateral lung\n  + Contralateral pleura (direct contiguous extension)\n  + Contralateral pleura/chest wall (discontinuous involvement)\n  + Heart muscle\n  + Intra-abdominal organs\n  + Mediastinal organs (discontinuous involvement)\n  + Mesothelioma WITH malignant pleural fluid\n  + Pericardial effusion, malignant\n  + Pericardium WITH pericardial effusion\n  + Peritoneum (direct transdiaphragmatic extension of tumor)\n  + Peritoneum (discontinuous extension of tumor)\n  + Pleural effusion (see note 2)\n  + Spine\n- Distant lymph node(s), NOS\n  + Hilar (contralateral, bilateral)\n     * Bronchopulmonary\n     * Proximal lobar\n     * Pulmonary root\n  + Mediastinal (contralateral, bilateral)\n     * Anterior\n     * Posterior (tracheoesophageal)\n  + Peridiaphragmatic (ipsilateral, contralateral)\n    * Mediastinal\n  + Scalene (ipsilateral, contralateral) \n    * Inferior deep cervical\n  + Supraclavicular (ipsilateral or contralateral)\n    * Transverse cervical\n- Distant metastasis, NOS\n  + Carcinomatosis\n  + Distant metastasis WITH or WITHOUT distant lymph node(s)" ], [ "9", "Unknown if extension or metastasis" ] ]
}